Aggrastat GPIIb/IIIa inhibitor data

The results of the randomized, double-blind, placebo-controlled RESTORE trial of Aggrastat in 2,139 patients undergoing angioplasty

Read the full 162 word article

How to gain access

Continue reading with a
two-week free trial.